BIIB - CIK 0000875045
The table below shows BIOGEN INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $1.95B | $2.21B | $2.27B | $2.27B | $2.47B | $2.51B |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.19B |
| $8.94B |
| $7.97B |
| $7.63B |
| $6.83B |
| $7.11B |
| Property, plant & equipment | $3.02B | $3.08B | $3.10B | $3.13B | $3.21B | $3.25B |
| Goodwill | $6.49B | $6.49B | $6.49B | $6.48B | $6.49B | $6.23B |
| Total assets | $29.48B | $29.21B | $28.33B | $28.03B | $28.31B | $26.80B |
| Accounts payable | $358.50M | $413.10M | $408.40M | $391.50M | $422.70M | $354.50M |
| Total current liabilities | $3.00B | $3.29B | $3.18B | $5.30B | $5.42B | $3.11B |
| Long-term debt | $6.29B | $6.29B | $6.28B | $4.55B | $4.55B | $6.29B |
| Total liabilities | $10.83B | $11.00B | $10.70B | $11.05B | $11.95B | $10.91B |
| Retained earnings | $20.87B | $20.60B | $20.14B | $19.50B | $18.99B | $18.60B |
| Total equity | - | - | - | - | - | - |